Trials / Completed
CompletedNCT06163937
Acute Effects of Fruit Juices Consumption on Postprandial Glycemic Responses and Satiety
Examining the Acute Effects of Two Different Fruit Juices (Orange Juice and Mixed Fruit Juice Consisted of Apple, Orange, Grape, and Pomegranate) on Postprandial Glycemic Responses and Satiety in Healthy Individuals
- Status
- Completed
- Phase
- N/A
- Study type
- Interventional
- Enrollment
- 10 (actual)
- Sponsor
- Agricultural University of Athens · Academic / Other
- Sex
- All
- Age
- 18 Years – 55 Years
- Healthy volunteers
- Accepted
Summary
This study investigated the acute effects of two fruit juices on postprandial glycemic responses and satiety in healthy individuals
Detailed description
This study aimed to 1. Determine the glycemic index and glycemic load of two types of fruit juices (orange juice and mixed fruit juice consisted of apple, orange, grape, and pomegranate) and 2. Investigate the effects of these two fruit juices on postprandial glycemic responses and satiety in healthy individuals
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| OTHER | Glucose as reference food | Ten healthy, normal-weight subjects after 10-14 hours of fasting, consumed 50g glucose diluted in 300ml water, tested three times, in different visits, within 5-10min. Fingertip capillary blood glucose samples were taken at baseline, 15, 30, 45, 60, 90 and 120 min. |
| OTHER | Orange juice | Ten healthy, normal-weight subjects after 10-14 hours of fasting, consumed 50g available carbohydrates from orange juice, tested once, within 5-10min. Fingertip capillary blood glucose samples were taken at baseline, 15, 30, 45, 60, 90 and 120 min. |
| OTHER | Mixed fruit juice | Ten healthy, normal-weight subjects after 10-14 hours of fasting, consumed 50g available carbohydrates from mixed fruit juice (consisted of apple, orange, grape, and pomegranate), tested once, within 5-10min. Fingertip capillary blood glucose samples were taken at baseline, 15, 30, 45, 60, 90 and 120 min. |
Timeline
- Start date
- 2023-09-01
- Primary completion
- 2023-10-15
- Completion
- 2023-10-30
- First posted
- 2023-12-11
- Last updated
- 2024-06-14
Locations
2 sites across 1 country: Greece
Source: ClinicalTrials.gov record NCT06163937. Inclusion in this directory is not an endorsement.